Background: Recent studies have implicated inflammatory processes in the pathophysiology of posttraumatic stress disorder (PTSD). C-reactive protein (CRP) is a widely-used measure of peripheral inflammation, but little is known about the genetic and epigenetic factors that influence blood levels of C-reactive protein (CRP) in individuals with PTSD. Methods: Participants were 286 U.S. military veterans of post-9/11 conflicts (57% with current PTSD). Analyses focused on single nucleotide polymorphisms (SNPs) in the CRP gene and DNA methylation at cg10636246 in AIM2-a locus recently linked to CRP levels through results from a large-scale epigenome-wide association study. Results: PTSD was positively correlated with serum CRP levels with PTSD cases more likely to have CRP levels in the clinically-elevated range compared to those without a PTSD diagnosis. Multivariate analyses that controlled for white blood cell proportions, genetic principal components, age and sex, showed this association to be mediated by methylation at the AIM2 locus. rs3091244, a functional SNP in the CRP promoter region, moderated the association between lifetime trauma exposure and current PTSD severity. Analyses also revealed that the top SNPs from the largest genome-wide association study of CRP conducted to date (rs1205 and rs2794520) significantly interacted with PTSD to influence CRP levels. Conclusions: These findings provide new insights into genetic and epigenetic mechanisms of inflammatory processes in the pathophysiology of PTSD and point to new directions for biomarker identification and treatment development for patients with PTSD.
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Introduction
Findings from recent genetic and blood-biomarker studies provide converging evidence for the role of inflammatory processes in the pathophysiology of PTSD. Plasma and serum studies have found elevated levels of various inflammatory markers in PTSD patients compared to controls and a recent meta-analysis of findings from 20 publications found the diagnosis to be reliably associated with elevated levels of circulating peripheral IL-6, IL-1b, TNFa, and interferon ! (Passos et al., 2015) . Genetic association studies have linked inflammation-related genes to risk for PTSD and a network analysis showed that inflammation-related genes, including TNFa and IL-1b, are also involved in regulation of PTSD-associated genes (Pollard et al., 2016) . Differential DNA methylation (DNAm) and/or expression of inflammation and immune system genes have also been reported in several studies (Breen et al., 2015; Dehghan et al., 2011; Smith et al., 2011; Zieker et al., 2007) .
One of the most extensively validated and widely studied markers of peripheral inflammation is C-reactive protein (CRP), a protein found in blood that responds to inflammatory stimuli by triggering cellular reactions that lead to their clearance. CRP is a highly sensitive inflammatory reactant produced primarily in the liver that increases dramatically in response to relevant stimuli. Though it
